These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 15764699
1. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H, Hla T. Proc Natl Acad Sci U S A; 2005 Mar 22; 102(12):4312-7. PubMed ID: 15764699 [Abstract] [Full Text] [Related]
2. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. Arterioscler Thromb Vasc Biol; 2007 Jun 22; 27(6):1312-8. PubMed ID: 17431187 [Abstract] [Full Text] [Related]
3. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Lepley D, Paik JH, Hla T, Ferrer F. Cancer Res; 2005 May 01; 65(9):3788-95. PubMed ID: 15867375 [Abstract] [Full Text] [Related]
4. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. J Biol Chem; 2003 Oct 10; 278(41):40057-66. PubMed ID: 12869565 [Abstract] [Full Text] [Related]
5. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A. Science; 2004 Feb 20; 303(5661):1179-81. PubMed ID: 14976311 [Abstract] [Full Text] [Related]
6. Regulation of PTEN by Rho small GTPases. Li Z, Dong X, Wang Z, Liu W, Deng N, Ding Y, Tang L, Hla T, Zeng R, Li L, Wu D. Nat Cell Biol; 2005 Apr 20; 7(4):399-404. PubMed ID: 15793569 [Abstract] [Full Text] [Related]
7. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Wishart MJ, Dixon JE. Trends Cell Biol; 2002 Dec 20; 12(12):579-85. PubMed ID: 12495846 [Abstract] [Full Text] [Related]
8. Pten signaling in gliomas. Knobbe CB, Merlo A, Reifenberger G. Neuro Oncol; 2002 Jul 20; 4(3):196-211. PubMed ID: 12084351 [Abstract] [Full Text] [Related]
9. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Malchinkhuu E, Sato K, Maehama T, Mogi C, Tomura H, Ishiuchi S, Yoshimoto Y, Kurose H, Okajima F. Biochem Biophys Res Commun; 2008 Feb 22; 366(4):963-8. PubMed ID: 18088600 [Abstract] [Full Text] [Related]
10. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Liu F, Verin AD, Wang P, Day R, Wersto RP, Chrest FJ, English DK, Garcia JG. Am J Respir Cell Mol Biol; 2001 Jun 22; 24(6):711-9. PubMed ID: 11415936 [Abstract] [Full Text] [Related]
11. Roles of PDK-1 and PKN in regulating cell migration and cortical actin formation of PTEN-knockout cells. Lim MA, Yang L, Zheng Y, Wu H, Dong LQ, Liu F. Oncogene; 2004 Dec 16; 23(58):9348-58. PubMed ID: 15531926 [Abstract] [Full Text] [Related]
12. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis. Del Galdo S, Vettel C, Heringdorf DM, Wieland T. Cell Signal; 2013 Dec 16; 25(12):2478-84. PubMed ID: 23993968 [Abstract] [Full Text] [Related]
14. PTEN gene and integrin signaling in cancer. Tamura M, Gu J, Tran H, Yamada KM. J Natl Cancer Inst; 1999 Nov 03; 91(21):1820-8. PubMed ID: 10547389 [Abstract] [Full Text] [Related]
15. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. White ES, Atrasz RG, Dickie EG, Aronoff DM, Stambolic V, Mak TW, Moore BB, Peters-Golden M. Am J Respir Cell Mol Biol; 2005 Feb 03; 32(2):135-41. PubMed ID: 15539459 [Abstract] [Full Text] [Related]
16. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Science; 1998 Jun 05; 280(5369):1614-7. PubMed ID: 9616126 [Abstract] [Full Text] [Related]
17. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt. Seminario MC, Precht P, Bunnell SC, Warren SE, Morris CM, Taub D, Wange RL. Eur J Immunol; 2004 Nov 05; 34(11):3165-75. PubMed ID: 15468057 [Abstract] [Full Text] [Related]
18. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER, Rhee SG. Proc Natl Acad Sci U S A; 2004 Nov 23; 101(47):16419-24. PubMed ID: 15534200 [Abstract] [Full Text] [Related]
19. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells. Kim KY, Lee JH, Park JH, Yoo MA, Kwak YG, Kim SO, Yoo SE, Hong KW. Eur J Pharmacol; 2004 Aug 30; 497(3):267-77. PubMed ID: 15336944 [Abstract] [Full Text] [Related]
20. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Balthasar S, Samulin J, Ahlgren H, Bergelin N, Lundqvist M, Toescu EC, Eggo MC, Törnquist K. Biochem J; 2006 Sep 15; 398(3):547-56. PubMed ID: 16753042 [Abstract] [Full Text] [Related] Page: [Next] [New Search]